278 related articles for article (PubMed ID: 26703728)
1. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test.
Worbs S; Fiebig U; Zeleny R; Schimmel H; Rummel A; Luginbühl W; Dorner BG
Toxins (Basel); 2015 Nov; 7(12):4935-66. PubMed ID: 26703724
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
Bigalke H; Rummel A
Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
[TBL] [Abstract][Full Text] [Related]
4. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
[TBL] [Abstract][Full Text] [Related]
5. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
[TBL] [Abstract][Full Text] [Related]
6. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
Sharma SK; Ferreira JL; Eblen BS; Whiting RC
Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
[TBL] [Abstract][Full Text] [Related]
7. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples.
Kalb SR; Moura H; Boyer AE; McWilliams LG; Pirkle JL; Barr JR
Anal Biochem; 2006 Apr; 351(1):84-92. PubMed ID: 16500606
[TBL] [Abstract][Full Text] [Related]
8. A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo.
Donald S; Elliott M; Gray B; Hornby F; Lewandowska A; Marlin S; Favre-Guilmard C; Périer C; Cornet S; Kalinichev M; Krupp J; Fonfria E
Pharmacol Res Perspect; 2018 Dec; 6(6):e00446. PubMed ID: 30519475
[TBL] [Abstract][Full Text] [Related]
9. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.
Burgin D; Périer C; Hackett G; Elliott M; Kwan D; Hornby F; Mir I; Maignel J; Liu SM; Beard M
Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941672
[TBL] [Abstract][Full Text] [Related]
10. Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.
Kalb SR; Baudys J; Wang D; Barr JR
Toxins (Basel); 2015 May; 7(5):1765-78. PubMed ID: 25996606
[TBL] [Abstract][Full Text] [Related]
11. Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection.
Perry MJ; Centurioni DA; Davis SW; Hannett GE; Musser KA; Egan CT
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28282915
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
14. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
15. Progress in cell based assays for botulinum neurotoxin detection.
Pellett S
Curr Top Microbiol Immunol; 2013; 364():257-85. PubMed ID: 23239357
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin detection and differentiation by mass spectrometry.
Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
[TBL] [Abstract][Full Text] [Related]
17. Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay.
Drigo I; Tonon E; Pascoletti S; Anniballi F; Kalb SR; Bano L
Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374240
[TBL] [Abstract][Full Text] [Related]
18. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.
Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
Anal Chem; 2014 Apr; 86(7):3254-62. PubMed ID: 24605815
[TBL] [Abstract][Full Text] [Related]
19. Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples.
Simon S; Fiebig U; Liu Y; Tierney R; Dano J; Worbs S; Endermann T; Nevers MC; Volland H; Sesardic D; Dorner MB
Toxins (Basel); 2015 Nov; 7(12):5011-34. PubMed ID: 26703727
[TBL] [Abstract][Full Text] [Related]
20. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
